Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: cell-penetrating polypeptides - Innate Biologics/The University of Munster

Next Previous
Drug Profile

Research programme: cell-penetrating polypeptides - Innate Biologics/The University of Munster

Alternative Names: Cell-penetrating bacterial effector polypeptides - Innate Biologics/The University of Munster

Latest Information Update: 31 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator The University of Munster
  • Developer Innate Biologics; The University of Munster
  • Class Anti-inflammatories; Antineoplastics; Bacterial proteins; Hepatoprotectants; Peptides; Skin disorder therapies
  • Mechanism of Action Cell membrane permeability enhancers; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Brain disorders; Cancer; Digestive system disorders; Joint disorders; Kidney disorders; Liver disorders; Skin disorders

Most Recent Events

  • 31 Mar 2024 Research programme is still in preclinical development in Skin-disorders in USA and Germany (Topical) (Innate Biologics pipeline, March 2024)
  • 28 Mar 2024 Preclinical trials in Brain disorders in USA, Germany (Topical) (Innate Biologics pipeline, March 2024)
  • 28 Mar 2024 Preclinical trials in Cancer in Germany, USA (Topical)(Innate Biologics pipeline, March 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top